Predictions
Qualigen Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.72
22.11.22
22.11.22
-
22.11.23
22.11.23
-66.14%
23.11.23
23.11.23
Could be worthwhile Investment >10% per year
Crossject S.A.
Start price
Target price
Perf. (%)
€4.04
12.11.22
12.11.22
€4.50
12.11.23
12.11.23
5.82%
13.11.23
13.11.23
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.96
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.38
29.10.23
29.10.23
€2.80
30.09.25
30.09.25
-
30.10.23
30.10.23
Could be very worthwhile Investment >20% year
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.28
01.10.23
01.10.23
€2.00
30.09.25
30.09.25
14.84%
29.10.23
29.10.23
Could be very worthwhile Investment >20% year
CEL-SCI Corp.
Start price
Target price
Perf. (%)
€1.51
23.10.23
23.10.23
-
23.10.24
23.10.24
-23.18%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.64
30.09.23
30.09.23
€1.00
30.09.24
30.09.24
-9.76%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Cellectis SA ADR
Start price
Target price
Perf. (%)
€2.32
07.10.22
07.10.22
€5.00
07.10.23
07.10.23
-43.97%
08.10.23
08.10.23
Could be worthwhile Investment >10% per year
Eurobio scientific
Start price
Target price
Perf. (%)
€17.24
05.10.22
05.10.22
€18.00
05.10.23
05.10.23
-24.25%
06.10.23
06.10.23
Could be worthwhile Investment >10% per year
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.05
24.06.23
24.06.23
€2.50
24.06.24
24.06.24
-83.41%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€1.81
16.09.23
16.09.23
€1.00
16.09.24
16.09.24
-22.10%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€5.11
16.09.23
16.09.23
€2.00
16.09.24
16.09.24
-14.09%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Pulse Biosciences Inc
Start price
Target price
Perf. (%)
€4.58
13.04.23
13.04.23
-
13.04.26
13.04.26
-14.85%
26.09.23
26.09.23
Risky Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.97
03.09.23
03.09.23
-
03.09.24
03.09.24
-21.32%
13.09.23
13.09.23
Risky Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.40
11.09.23
11.09.23
-
11.09.24
11.09.24
-22.50%
12.09.23
12.09.23
Probably not worthwhile Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.97
03.09.23
03.09.23
€2.50
31.07.25
31.07.25
18.78%
06.09.23
06.09.23
Could be very worthwhile Investment >20% year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€4.55
06.09.22
06.09.22
-
06.09.23
06.09.23
-53.45%
06.09.23
06.09.23
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€3.79
27.12.22
27.12.22
-
27.12.23
27.12.23
-90.75%
29.07.23
29.07.23
Capable Management
Risky Investment
No uniques
No Innovation